As of May 23, 2025, Plant Health Care PLC has a Discounted Cash Flow (DCF) derived fair value of $0.00 per share. With the current market price at $8.93, this represents a potential upside of -1423.9%.
| Key Metrics | Value |
|---|---|
| DCF Fair Value (5-year) | $0.00 |
| DCF Fair Value (10-year) | $0.00 |
| Potential Upside (5-year) | -1177.2% |
| Potential Upside (10-year) | -1423.9% |
| Discount Rate (WACC) | 6.1% - 8.6% |
Revenue is projected to grow from $11 million in 12-2023 to $75 million by 12-2033, representing a compound annual growth rate of approximately 21.2%.
| Fiscal Year | Revenue (USD millions) | Growth |
|---|---|---|
| 12-2023 | 11 | 5% |
| 12-2024 | 16 | 38% |
| 12-2025 | 24 | 56% |
| 12-2026 | 30 | 26% |
| 12-2027 | 36 | 19% |
| 12-2028 | 42 | 15% |
| 12-2029 | 49 | 16% |
| 12-2030 | 55 | 13% |
| 12-2031 | 62 | 13% |
| 12-2032 | 69 | 11% |
| 12-2033 | 75 | 9% |
Net profit margin is expected to improve from -36% in 12-2023 to -29% by 12-2033, driven by operational efficiency and economies of scale.
| Fiscal Year | Net Profit (USD millions) | Profit Margin |
|---|---|---|
| 12-2023 | (4) | -36% |
| 12-2024 | (6) | -37% |
| 12-2025 | (9) | -35% |
| 12-2026 | (10) | -34% |
| 12-2027 | (12) | -32% |
| 12-2028 | (13) | -30% |
| 12-2029 | (15) | -30% |
| 12-2030 | (16) | -30% |
| 12-2031 | (18) | -29% |
| 12-2032 | (20) | -29% |
| 12-2033 | (22) | -29% |
with a 5-year average of $2 million. Projected CapEx is expected to maintain at approximately 22% of revenue.
Depreciation is based on an average useful life of 5 years for capital assets.
| Fiscal Year | D&A (USD millions) |
|---|---|
| 12-2024 | 3 |
| 12-2025 | 4 |
| 12-2026 | 3 |
| 12-2027 | 5 |
| 12-2028 | 7 |
| 12-2029 | 8 |
Net working capital is expected to increase gradually, with projected changes affecting free cash flow.
| Components | Average Days |
|---|---|
| Days Receivables | 93 |
| Days Inventory | 247 |
| Days Payables | 120 |
| Fiscal Year | EBITDA | Tax | CapEx | Change in NWC | FCF |
|---|---|---|---|---|---|
| 2024 | (4) | (0) | 3 | 1 | (8) |
| 2025 | (5) | (0) | 5 | 3 | (13) |
| 2026 | (8) | (0) | 7 | 3 | (17) |
| 2027 | (7) | (0) | 8 | 2 | (17) |
| 2028 | (7) | (0) | 9 | 2 | (17) |
| Valuation Method | Fair Price (USD) | Potential Upside |
|---|---|---|
| 5-Year DCF (Growth) | 0.00 | -1177.2% |
| 10-Year DCF (Growth) | 0.00 | -1423.9% |
| 5-Year DCF (EBITDA) | 0.00 | -100.0% |
| 10-Year DCF (EBITDA) | 0.00 | -100.0% |
Is Plant Health Care PLC (PHC.L) a buy or a sell? Plant Health Care PLC is definitely a sell. Based on our DCF analysis, Plant Health Care PLC (PHC.L) appears to be overvalued with upside potential of -1423.9%. The company's strong projected growth in revenue and profitability, coupled with consistent capital expenditure, supports our positive outlook on its intrinsic value.
Key investment drivers include:
Investors should consider reducing exposure at the current market price of $8.93.